Properties
What is it?
REMAXOL® Trade Name: REMAXOL® Group Name: Inosine + Meglumine + Methionine + Nicotinamide + Succinic Acid Dosage Form: Solution for Infusion Composition: Active Ingredients: Succinic acid - 5.280 g; Meglumine (N-methylglucamine) - 8.725 g; Inosine (Riboxin) - 2.0 g; Methionine - 0.75 g, Nicotinamide - 0.25 g. Excipients: Sodium chloride - 6.0 g; Potassium chloride - 0.30 g; Magnesium chloride hexahydrate (calculated on anhydrous basis) - 0.12 g; Sodium hydroxide - 1.788 g; Water for injections up to 1.0 L. Description: Clear, colorless liquid with a faint characteristic odor. Pharmacotherapeutic Group: Metabolic agent. Indications Liver function disorders in case of acute or chronic damage (toxic, alcoholic, drug-induced hepatitis). In complex treatment of viral hepatitis (as an adjunct to etiotropic therapy). Contraindications Individual intolerance to the drug components, pregnancy, lactation period, childhood. Precautions Nephrolithiasis, gout, hyperuricemia. Method of Administration and Dosage REMAXOL® is administered only intravenously, by drip infusion, with a daily dose of up to 400-800 ml for 3-12 days, depending on the severity of the disease. Infusion rate - 40-60 drops (2-3 ml) per minute. Side Effects With rapid infusion of the solution, undesirable reactions may occur (erythema of the skin of varying degrees, feeling of heat, tickling in the throat, dry mouth), which do not require discontinuation of the drug. Allergic reactions are possible in the form of allergic rash and skin itching, which are resolved by taking antihistamines. Rare undesirable reactions include nausea, headache, and dizziness. Due to the activation of aerobic processes in the body by the drug, a decrease in glucose concentration and an increase in urea concentration in the blood are possible. Overdose There are no reports of drug overdose. Interaction with Other Drugs It is not recommended to mix with other drugs for intravenous use in the same vial.